Prevention of Alzheimer's disease (Q22248031)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Prevention of Alzheimer's disease	scientific article

Statements

scholarly article

0 references

1 reference

Europe PubMed Central

Prevention of Alzheimer's disease (English)

0 references

Alzheimer's disease

1 reference

based on heuristic

inferred from title

author name string

C. A. Szekely

1

author given names

C A

author last names

Szekely

1 reference

PubMed publication ID

8 February 2023

J. C. S. Breitner

2

author given names

J C S

author last names

Breitner

1 reference

PubMed publication ID

8 February 2023

P. P. Zandi

3

author given names

P P

author last names

Zandi

1 reference

PubMed publication ID

8 February 2023

language of work or name

0 references

publication date

January 2007

0 references

International Review of Psychiatry

0 references

19

0 references

6

0 references

693-706

0 references

Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial

1 reference

https://api.crossref.org/works/10.1080/09540260701797944

20 April 2017

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

1 reference

https://api.crossref.org/works/10.1080/09540260701797944

20 April 2017

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

1 reference

https://api.crossref.org/works/10.1080/09540260701797944

20 April 2017

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Randomized pilot study of nimesulide treatment in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Resveratrol--a boon for treating Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

High-dose estradiol improves cognition for women with AD: results of a randomized study

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Effects of cognitive training interventions with older adults: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Exercise primes a molecular memory for brain-derived neurotrophic factor protein induction in the rat hippocampus

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Use of ramipril in preventing stroke: double blind randomised trial

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Analysis of plasma tocopherols alpha, gamma, and 5-nitro-gamma in rats with inflammation by HPLC coulometric detection

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Fitness effects on the cognitive function of older adults: a meta-analytic study

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Intake of flavonoids and risk of dementia

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Aspirin, NSAIDs, risk of dementia, and influence of the apolipoprotein E epsilon 4 allele in an elderly population

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Reduced risk of Alzheimer's disease with high folate intake: the Baltimore Longitudinal Study of Aging

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Exercise: a behavioral intervention to enhance brain health and plasticity

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Insulin resistance syndrome and Alzheimer's disease: age- and obesity-related effects on memory, amyloid, and inflammation

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Dietary intake of antioxidants and risk of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Global prevalence of dementia: a Delphi consensus study

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Dementia and Alzheimer's disease in community-dwelling elders taking vitamin C and/or vitamin E.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

An active and socially integrated lifestyle in late life might protect against dementia

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Ginkgo biloba: A Cognitive Enhancer?

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Association between nutritional status and cognitive functioning in a healthy elderly population.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Apolipoprotein E genotypes and the incidence of Alzheimer's disease among persons aged 75 years and older: variation by use of antihypertensive medication?

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Alzheimer Disease in the US Population

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Epidemiology of dementia and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Increasing testosterone levels and effects on cognitive functions in elderly men and women: a review.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Gamma-tocopherol supplementation inhibits protein nitration and ascorbate oxidation in rats with inflammation

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Diet and the risk for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Antihypertensive medication use and incident Alzheimer disease: the Cache County Study.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Ginkgo biloba for cerebral insufficiency

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Demonstrating the case that AD is a vascular disease: epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Antioxidant vitamin intake and risk of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Hyperinsulinemia and risk of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Double placebo design in a prevention trial for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Association of vitamin E and C supplement use with cognitive function and dementia in elderly men.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Total serum homocysteine in senile dementia of Alzheimer type

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Anti-inflammatory drugs and Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Use of antioxidant supplements and its association with cognitive function in a rural elderly cohort: the MoVIES Project. Monongahela Valley Independent Elders Survey

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Free testosterone and risk for Alzheimer disease in older men

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Arundic Acid ameliorates cerebral amyloidosis and gliosis in Alzheimer transgenic mice

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Curry consumption and cognitive function in the elderly

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Cohort study of vitamin C intake and cognitive impairment.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Mediterranean diet and cognitive decline.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

The relation between antioxidants and memory performance in the old and very old.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Vitamin E and donepezil for the treatment of mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Obesity, abdominal obesity and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Statin Use and the Risk of Incident Dementia

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Relation of plasma lipids to Alzheimer disease and vascular dementia

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Use of lipid-lowering drugs in older adults with and without dementia: a community-based epidemiological study

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Links between the pathology of Alzheimer's disease and vascular dementia

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Effect of pharmacologic lipid lowering on health-related quality of life in older persons: results from the Cholesterol Reduction in Seniors Program (CRISP) Pilot Study.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Mediterranean diet and risk for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Alzheimer disease: mechanistic understanding predicts novel therapies

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Update on hypertension and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Brain infarction and the clinical expression of Alzheimer disease. The Nun Study

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Statin therapy in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Cognitive reserve and Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Risk of Alzheimer's disease and duration of NSAID use.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

NSAIDs for the Chemoprevention of Alzheimer’s Disease

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Prevention of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Association of metabolic syndrome with Alzheimer disease: a population-based study.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

The GuidAge study: methodological issues. A 5-year double-blind randomized trial of the efficacy of EGb 761 for prevention of Alzheimer disease in patients over 70 with a memory complaint

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Immunology and immunotherapy of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Long-term effects of cognitive training on everyday functional outcomes in older adults

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

DHEA treatment of Alzheimer's disease: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Nonsteroidal anti-inflammatory drug use and Alzheimer's disease risk: the MIRAGE Study

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Thiazolidinediones

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Nonfasting Plasma Total Homocysteine Levels and Stroke Incidence in Elderly Persons: The Framingham Study

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Antihypertensive drugs and incidence of dementia: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

21 January 2018

Effects of Estrogen Plus Progestin on Risk of Dementia

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

7 January 2021

based on heuristic

inferred from DOI database lookup

Behavior-based interventions to enhance cognitive functioning and independence in older adults

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of mortality with vitamin E supplements: the Cache County study

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic oxidative stress and cognitive performance in the population-based EVA study. Etude du Vieillissement Artériel

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

7 January 2021

based on heuristic

inferred from DOI database lookup

A longitudinal study of factors predicting change in cognitive test scores over time, in an older hypertensive population.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

7 January 2021

based on heuristic

inferred from DOI database lookup

Folates and prevention of disease

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

7 January 2021

based on heuristic

inferred from DOI database lookup

Nutritional status and cognitive functioning in a normally aging sample: a 6-y reassessment.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

7 January 2021

based on heuristic

inferred from DOI database lookup

Citrus fruit supplementation reduces lipoprotein oxidation in young men ingesting a diet high in saturated fat: presumptive evidence for an interaction between vitamins C and E in vivo

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

7 January 2021

based on heuristic

inferred from DOI database lookup

The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse.

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

7 January 2021

based on heuristic

inferred from DOI database lookup

Dietary folate and vitamins B-12 and B-6 not associated with incident Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

7 January 2021

based on heuristic

inferred from DOI database lookup

An editorial update: Annus horribilis for vitamin E

1 reference

https://api.crossref.org/works/10.1080%2F09540260701797944

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1080/09540260701797944

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q22248031&oldid=1829304303"